This Dividend Stock Is Beating the S&P 500 by 170% in 2026
In 2026, AbbVie (ABBV) has outperformed the S&P 500 by an impressive 170%, with a 29% stock increase. Key highlights include a 2.47% dividend yield, over 13 years of consecutive increases, and a solid five-year growth rate of 5.88%. With a manageable payout ratio of 52% and strong revenue growth driven by key products, AbbVie...
Read More >


